Evidence method
Level · gp.fundamentals.capex_revenue_ratio
117.31% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
BRTX · Dec 31, 2023
BioRestorative Therapies, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001493152-24-023479General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-4410.30% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
21.70% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-10439.49% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2767.21% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
5338.11% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History56 statesSelf-history eligible
Sep 30, 20215/6 normalizedLevel 3Dec 31, 20216/7 normalizedLevel 3Mar 31, 20226/6 normalizedLevel 3Jun 30, 20226/6 normalizedLevel 3Sep 30, 20226/6 normalizedLevel 3Dec 31, 20226/6 normalizedLevel 3Mar 31, 20236/6 normalizedLevel 3Jun 30, 20236/6 normalizedLevel 3Sep 30, 20236/6 normalizedLevel 3Dec 31, 20236/6 normalizedLevel 3Dec 31, 20236/6 normalizedAmended as filedMar 31, 20245/5 normalizedLevel 3Jun 30, 20246/6 normalizedLevel 3Sep 30, 20247/7 normalizedLevel 3Dec 31, 20247/7 normalizedLevel 3Mar 31, 20257/7 normalizedLevel 3Jun 30, 20257/7 normalizedLevel 3Sep 30, 20257/7 normalizedLevel 3Dec 31, 20257/7 normalizedLevel 3Mar 31, 20266/6 normalizedLevel 4
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.